ARTICLE | Clinical News
SAR161271: Development discontinued
August 2, 2010 7:00 AM UTC
sanofi-aventis discontinued development of SAR161271 after the compound failed to meet predefined pharmacodynamic and pharmacokinetic requirements in Phase IIa testing. ...